title: [The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
authors.forename: Joana
authors.initials: J
authors.lastname: Nicolau Ramis
authors.forename: Lluís
authors.initials: L
authors.lastname: Masmiquel Comas
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D002116:Calcitonin / Q000378:metabolism; D018276:Carcinoma, Medullary / Q000139:chemically induced; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology; D018819:Dipeptidyl Peptidase 4 / Q000502:physiology; D004198:Disease Susceptibility; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000819:agonists / Q000031:analogs & derivatives; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D007239:Infections / Q000209:etiology; D000069450:Liraglutide; D010195:Pancreatitis / Q000139:chemically induced; D060735:Pharmacovigilance; D000077205:Pioglitazone; D011719:Pyrazines / Q000009:adverse effects; D018570:Risk Assessment; D056737:Safety-Based Drug Withdrawals; D000068900:Sitagliptin Phosphate; D013045:Species Specificity; D045162:Thiazolidinediones / Q000009:adverse effects / Q000633:toxicity; D013964:Thyroid Neoplasms / Q000139:chemically induced; D014230:Triazoles / Q000009:adverse effects; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents; D011719:Pyrazines; D045162:Thiazolidinediones; D014230:Triazoles; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D002116:Calcitonin; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D000068900:Sitagliptin Phosphate; D000077205:Pioglitazone